OKLO Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Advanced Nuclear Development ELBM Q4 2025 Earnings Deep EPS Miss Amid Strategic Progress Stock Gains Slightly Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 QUAD Q1 2026 Earnings EPS Beats Estimates by 14 Stock Climbs Marginally Cognition Therapeutics Inc CGTX Q1 2026 Earnings Narrower Loss on Lower Expenses No Revenue Reported TATT Q1 2026 Earnings Strong EPS Beat Drives Stock Rally